Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
66.16 USD | -1.15% | -3.63% | -18.33% |
12:33am | US FDA mandates label updates on CAR-T cancer therapies | RE |
Apr. 17 | UBS Adjusts Gilead Sciences Price Target to $75 From $81, Maintains Neutral Rating | MT |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.